Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Boehringer Ingelheim · Phase 2 · Completed · Enrollment 387

NCT04667377

EudraCT 2020-002479-37

ArmPopulationDoseWeeksEstimandWeight change
0.6 mg BI 456906Obesity or overweight0.6 mg46Efficacyn/r
Placebo groupObesity or overweightn/r46Efficacyn/r
2.4 mg BI456906Obesity or overweight2.4 mg46Efficacyn/r
3.6 mg BI 456906Obesity or overweight3.6 mg46Efficacyn/r
4.8 mg BI 456906Obesity or overweight4.8 mg46Efficacyn/r